Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,051 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study).
Tse KY, Wong RW, Chao A, Ueng SH, Yang LY, Cummings M, Smith D, Lai CR, Lau HY, Yen MS, Cheung AN, Leung CK, Chan KS, Chan AN, Li WH, Choi CK, Pong WM, Hui HF, Yuk JY, Yao H, Yuen NW, Obermair A, Lai CH, Ip PP, Ngan HY. Tse KY, et al. Among authors: cummings m. Cancers (Basel). 2021 May 14;13(10):2378. doi: 10.3390/cancers13102378. Cancers (Basel). 2021. PMID: 34069227 Free PMC article.
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
Walsh MD, Cummings MC, Buchanan DD, Dambacher WM, Arnold S, McKeone D, Byrnes R, Barker MA, Leggett BA, Gattas M, Jass JR, Spurdle AB, Young J, Obermair A. Walsh MD, et al. Among authors: cummings mc. Clin Cancer Res. 2008 Mar 15;14(6):1692-700. doi: 10.1158/1078-0432.CCR-07-1849. Epub 2008 Feb 29. Clin Cancer Res. 2008. PMID: 18310315 Free article.
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial.
Janda M, Robledo KP, Gebski V, Armes JE, Alizart M, Cummings M, Chen C, Leung Y, Sykes P, McNally O, Oehler MK, Walker G, Garrett A, Tang A, Land R, Nicklin JL, Chetty N, Perrin LC, Hoet G, Sowden K, Eva L, Tristram A, Obermair A. Janda M, et al. Among authors: cummings m. Gynecol Oncol. 2021 Apr;161(1):143-151. doi: 10.1016/j.ygyno.2021.01.029. Gynecol Oncol. 2021. PMID: 33762086 Free article. Clinical Trial.
Corrigendum to "Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial" [Gynecologic Oncology 161 (2021) 143-151].
Janda M, Robledo KP, Gebski V, Armes JE, Alizart M, Brennan D, Cummings M, Chen C, Leung Y, Sykes P, McNally O, Oehler MK, GraemeWalker, Garrett A, Tang A, Land R, Nicklin JL, Chetty N, Perrin LC, Hoet G, Sowden K, Eva L, Tristram A, Obermair A. Janda M, et al. Among authors: cummings m. Gynecol Oncol. 2021 Aug;162(2):526. doi: 10.1016/j.ygyno.2021.05.016. Epub 2021 May 28. Gynecol Oncol. 2021. PMID: 34053746 Free article. No abstract available.
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB. Buchanan DD, et al. Among authors: cummings m. J Clin Oncol. 2014 Jan 10;32(2):90-100. doi: 10.1200/JCO.2013.51.2129. Epub 2013 Dec 9. J Clin Oncol. 2014. PMID: 24323032 Free PMC article.
Reply to J. Moline et al.
Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB. Buchanan DD, et al. Among authors: cummings m. J Clin Oncol. 2014 Jul 20;32(21):2278-9. doi: 10.1200/JCO.2014.55.8213. Epub 2014 Jun 9. J Clin Oncol. 2014. PMID: 24912891 No abstract available.
Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis.
Nagle CM, Olsen CM, Ibiebele TI, Spurdle AB, Webb PM; Astralian National Endometrial Cancer Study Group; Astralian Ovarian Cancer Study Group. Nagle CM, et al. Eur J Nutr. 2013 Mar;52(2):705-15. doi: 10.1007/s00394-012-0376-7. Epub 2012 May 22. Eur J Nutr. 2013. PMID: 22648201 Review.
Undifferentiated uterine sarcoma: a multidisciplinary challenge.
Allanson ER, Cummings M, Kuchel A, Wastney T, Nicklin J. Allanson ER, et al. Among authors: cummings m. Int J Gynecol Cancer. 2022 Feb;32(2):198-202. doi: 10.1136/ijgc-2021-003215. Int J Gynecol Cancer. 2022. PMID: 35131912 No abstract available.
Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis.
Dong Y, Walsh MD, McGuckin MA, Gabrielli BG, Cummings MC, Wright RG, Hurst T, Khoo SK, Parsons PG. Dong Y, et al. Among authors: cummings mc. Int J Cancer. 1997 Feb 20;74(1):57-63. doi: 10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f. Int J Cancer. 1997. PMID: 9036870 Free article.
1,051 results